Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5591)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 14, 2023 (publication date) through Jun 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheah E, Huang JG. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies. World J Gastroenterol 2023; 29(10): 1539-1550 [PMID: 36970587 DOI: 10.3748/wjg.v29.i10.1539] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i10/1539.htm |
| Number | Citing Articles |
| 1 |
Sidsel Støy, Silvia D’Alessio, Thomas Damgaard Sandahl, Anders Dige, Anne Louise Kjølbye, Rasmus Jorgensen, Silvio Danese, Martijn van de Bunt. Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis. Digestive Diseases and Sciences 2025; doi: 10.1007/s10620-025-09007-w
|
| 2 |
Luyao Liu, Fan Zhao, Dandan Han, Xin Lü, Gang Wu, Yanglei Yi. Liquiritigenin ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function, reducing endoplasmic reticulum stress and modulating gut microbiota. Journal of Functional Foods 2024; 122: 106541 doi: 10.1016/j.jff.2024.106541
|
| 3 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 4 |
Hua Huang, Jiaze Ma, An Kang, Tianwei Guo, Wei Sun, Yan Xu, Lijiang Ji. Investigating the molecular mechanisms associated with ulcerative colitis through the application of single-cell combined spatial transcriptome sequencing. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1534768
|
| 5 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(828) |
Core Tip(792) |
Full Article(HTML)(3898)
|
Full Article with Cover (PDF)-1825K(223)
|
Full Article (Word)-130K(39)
|
Audio-14227K(22)
|
Peer-Review Report-222K(96)
|
Answering Reviewers-194K(72)
|
Full Article (PDF)-407K(210)
|
Full Article (XML)-119K(100)
|
Times Cited (0)
|
Total Visits (11677)
|
Open
|
| 6 |
Danny Con, Peter De Cruz. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study. Intestinal Research 2024; 22(4): 439 doi: 10.5217/ir.2023.00175
|
| 7 |
Fang-Yuan Zheng, Kai-Si Yang, Wen-Cheng Min, Xin-Zhu Li, Yu Xing, Shuai Wang, Ying-Shi Zhang, Qing-Chun Zhao. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis. World Journal of Gastrointestinal Surgery 2024; 16(2): 571-584 doi: 10.4240/wjgs.v16.i2.571
Abstract(416) |
Core Tip(478) |
Full Article(HTML)(1430)
|
Full Article with Cover (PDF)-2615K(89)
|
Full Article (Word)-1431K(6)
|
Audio-2064K(4)
|
Peer-Review Report-254K(63)
|
Answering Reviewers-134K(56)
|
Supplementary Material-222K(54)
|
Full Article (PDF)-2359K(98)
|
Full Article (XML)-155K(60)
|
Times Cited (0)
|
Total Visits (5279)
|
Open
|
| 8 |
Daniel Schweckendiek, Gerhard Rogler. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?. Digestion 2024; 105(6): 411 doi: 10.1159/000540421
|